Next Article in Journal
Influence of a Natural Plant Antioxidant on the Ageing Process of Ethylene-norbornene Copolymer (Topas)
Next Article in Special Issue
Both Specific Endothelial and Proximal Tubular Adam17 Deletion Protect against Diabetic Nephropathy
Previous Article in Journal
Prospects of Polymeric Nanofibers Loaded with Essential Oils for Biomedical and Food-Packaging Applications
Previous Article in Special Issue
IL-33 Is Involved in the Anti-Inflammatory Effects of Butyrate and Propionate on TNFα-Activated Endothelial Cells
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 22
Issue 8
10.3390/ijms22084016
Review Report
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Review
Peer-Review Record

Cell-Mediated Therapies to Facilitate Operational Tolerance in Liver Transplantation

Int. J. Mol. Sci. 2021, 22(8), 4016; https://doi.org/10.3390/ijms22084016
by Samia D. Ellias 1, Ellen L. Larson 1, Timucin Taner 1,2 and Scott L. Nyberg 1,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Int. J. Mol. Sci. 2021, 22(8), 4016; https://doi.org/10.3390/ijms22084016
Submission received: 14 March 2021 / Revised: 9 April 2021 / Accepted: 12 April 2021 / Published: 13 April 2021
(This article belongs to the Special Issue Molecular Mechanisms of Damage and Regeneration in Disorders Associated with Abdominal Organs)

Round 1

Reviewer 1 Report

The manuscript by Ellias et al. reviews the latest cell based approaches to support operational tolerance after orthotopic liver transplantation.

The review focusses on the immunoprivileged status of the liver and provides an overview about the particular role of the liver cell types related to the tolergenicity. Additionally, the manuscript integrates literature from pre-clinical and clinical trails using cell therapeutics to foster the operational tolerance.  

The manuscript is well written and the figures illustrate the functions of the cell therapeutics to underline the possible mechanisms. 

line 376: 12. Future...: Please, may the authors consider to include the exosome topic or comment on that issue (for example: doi: 10.5500/wjt.v10.i11.330) 

minor points:

line 55: Please check cit. format

line 77 and 78; 329: Please check the status of the clinical trails, it would be helpfull to the readers to know the Phase of the trails.

line 121: please check the number of lymphocytes 

line 227; 249: please check the format of the cit.

line 257: please check period

line 266, 384: please check cit. format

Fig. 3: please check IDO and HLA-G5 hardly visible within the activated MSC. D. CD83 is missing, please check if CD83 could be add

 

 

 

 

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

The manuscript "Cell mediated therapies to facilitate operational tolerance in liver transplantation" by Ellias et al. reviews the latest cell based approaches to support operational tolerance after orthotopic liver transplantation.

Authors have achieved a good revision from the current state of cell therapy to induce tolerance in liver transplant in the review "Cell mediated therapies to facilitate operational tolerance in liver transplantation". I accept the manuscript in the current form, however there are some format mistakes with the references which has to be properly reviewed by the authors. For example in line 55 or 227. 

Author Response

Response to Reviewer 2 Comments

 

Point 1: there are some format mistakes with the references which has to be properly reviewed by the authors. For example in line 55 or 227. 

Response 1: line 54: [] added to reference 10

Line 220-249 - Format of citations changed for reference [57], [60], [61], [62]

Line 266: Reference [70] format changed

Line 383: Reference [98] format changed

Back to TopTop